Rikhsieva , O. ., & Rajabova , N. (2025). HIGH-COST ANTICANCER DRUGS: CLINICAL BENEFIT OR FINANCIAL BURDEN FOR THE HEALTHCARE SYSTEM?. Евразийский журнал академических исследований, 5(10(MPHAPP), 197. извлечено от https://inlibrary.uz/index.php/ejar/article/view/138339